Exosome-based immunotherapy

Cancer Immunology, Immunotherapy

Volumn 53, Issue 3, 2004, Pages 234-239

  Chaput, Nathalie ^a   Taïeb, Julien ^a,b   Schartz, Noël E C ^a,c   André, Fabrice ^a   Angevin, Eric ^a   Zitvogel, Laurence ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Cross presentation; Exosomes; Immunotherapy; MHC complexes; Tumor

Indexed keywords

AMPLIGEN; CANCER VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A1 ANTIGEN; HLA A2 ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELAN A; MELANOMA ANTIGEN; MELANOMA ANTIGEN 3; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BIOGENESIS; CANCER IMMUNOTHERAPY; CELL CULTURE; CELL FUNCTION; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; EPITHELIUM CELL; EXOSOME; HEMATOPOIETIC CELL; HUMAN; LIPID COMPOSITION; MELANOMA; MEMBRANE VESICLE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SIDE EFFECT;

ANTIGEN PRESENTATION; CANCER VACCINES; DENDRITIC CELLS; ENDOSOMES; HUMANS; IMMUNOTHERAPY; MELANOMA; NEOPLASMS;

EID: 12144287483     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0472-x     Document Type: Review

References (23)

1. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365-3374
2. Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 165:1259-1265
3. Quah B, O'Neill HC (2000) The application of dendritic cell-derived exosomes in tumour immunotherpy. Cancer Biother Radiopharm 15:185-194
4. André F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002) Malignant effusions and immunogenic tumor derived-exosomes. Lancet 360:295-305
5. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4:594-600
6. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297-303
7. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412-9420
8. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8:2631-2645
9. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:20121-20127
10. Arnold PY, Mannie MD (1999) Vesicles bearing MHC class II molecules mediate transfer of antigen-presenting cells to CD4+ cells. Eur J Immunol 29:1363-1373
11. Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG (1996) Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Investig 97:331-338
12. Hess C, Sadallah S, Hefti A, Landmann R, Schifferli JA (1999) Ectosomes released by human neutrophils are specialized functional units. J Immunol 163:4564-4573
13. Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD (1999) Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 163:5201-5210
14. Geminard C, Nault F, Johnstone RM, Vidal M (2001) Characteristics of the Interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation. J Biol Chem 276:9910-9916
15. Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mecheri S (2001) Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166:868-876
16. Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569-579
17. Yang S, Kittlesen D, Slingluff CL Jr, Vervaert CE, Seigler HF, Darrow TL (2000) Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J Immunol 164(8):4204-4211
18. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233-238
19. Chaput N, André F, Schartz NEC, Escudier B, Turz T, Angevin E, Zitvogel L (2003) Proc Am Assoc Cancer Res 44:A4746
20. Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S (2002) Exosomes activate naive CD4+ T cells by transfer of MHC/peptide complexes to dendritic cells. Nat Immunol 3:1156-1162
21. Lamparski H, Metha-Damani A, Yao J, Patel S, Hsu D, Ruegg C, Le Pecq J (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Meth 270(2):211
22. H. Pêche (2001) Club Francophone Des Cellules Dendritiques, p 31 (Abstract C08)
23. E. Angevin (2002) 7th International Symposium on Dendritic Cells, p 28 (Abstract 20)